Artificial intelligence is beginning to reshape how drug companies interact with the Food and Drug Administration, though most changes so far have been limited.

Liver disease is a growing health concern in the United States, affecting millions of adults. One of the most common types is ...

A compound derived from rosemary, known as carnosic acid, has been transformed into a potent brain-boosting drug that combats Alzheimer’s by reducing inflammation and stress in the brain — all while ...

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in ...

Under Proposition 36, the District Attorney has significantly increased felony convictions. But a part of the bill that ...

The drug is already approved for KMT2A-rearranged AML, and Syndax is hoping for approval in NPM1-mutated disease by the end of the year.

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

UroGen Pharma shares are surging this week after the company gained FDA approval for ZUSDURI. The positive clinical trial ...

Costa Rica’s US-donated drug scanners remain unused seven months after arrival, delaying port security upgrades at Caldera ...

The drug pipeline—the process through which a potential new drug gets discovered, tested, approved, and marketed—is a ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.